Summit Therapeutics (SMMT) Return on Sales (2017 - 2023)
Summit Therapeutics' (SMMT) quarterly Return on Sales came in at 27.48% in Q2 2023, down 2692.0% YoY from 1.06% in Q2 2022, and down 108.87% on a QoQ basis from 13.16% in Q1 2023.
Summit Therapeutics (SMMT) Return on Sales (2017 - 2023) Analysis & Trends
Summit Therapeutics (SMMT) has 7 years of Return on Sales data on file, last reported at 27.48% in Q2 2023.
- Quarterly Return on Sales fell 2692.0% year-over-year to 27.48% in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 27.48% (down 2708.0% YoY) and the FY2022 annual result came in at 1.12%, down 63.0% from the prior year.
- Return on Sales fell to 27.48% in Q2 2023, from 13.16% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2019 to a low of 27.48% in Q2 2023.
- A 5-year average of 2.88% and a median of 0.8% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales soared 372 bps — and 2023, when it slumped 2692 bps.
- Tracing SMMT's Return on Sales over 5 years: stood at 0.01% in 2019, then sank by 8520 bps to 0.73% in 2020, then plunged by 48 bps to 1.08% in 2021, then dropped by 1 bps to 1.09% in 2022, then tumbled by 2428 bps to 27.48% in 2023.
- The last three Return on Sales figures came in at 27.48% (Q2 2023), 13.16% (Q1 2023), and 1.09% (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -27.48% |
| Mar 31, 2023 | -13.16% |
| Dec 31, 2022 | -1.09% |
| Sep 30, 2022 | -0.80% |
| Jun 30, 2022 | -0.57% |
| Mar 31, 2022 | -0.90% |
| Dec 31, 2021 | -1.08% |
| Sep 30, 2021 | -0.15% |
| Jun 30, 2021 | -4.28% |
| Mar 31, 2021 | -0.91% |
| Dec 31, 2020 | -0.73% |
| Sep 30, 2020 | -0.98% |
| Jun 30, 2020 | -0.90% |
| Mar 31, 2020 | -0.20% |
| Dec 31, 2019 | 0.01% |
| Oct 31, 2019 | -0.57% |
| Sep 30, 2019 | -0.43% |
| Jul 31, 2019 | -0.41% |
| Mar 31, 2019 | -0.14% |
| Oct 31, 2018 | -0.12% |